REGN Regeneron Pharmaceuticals, Inc.
Healthcare$638.88-0.58%ClosedMarket Cap: $65.82B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$843.84
Target (Median)
$860.00
Target Range
$641.00 - $995.00
Upside from current price: 32.1%
Rating Distribution
5 Strong Buy18 Buy8 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-19 | Canaccord Genuity | maintain | Buy | Buy |
| 2026-05-18 | Citigroup | downgrade | Neutral | Buy |
| 2026-05-18 | Truist Securities | maintain | Buy | Buy |
| 2026-05-18 | JP Morgan | maintain | Overweight | Overweight |
| 2026-05-18 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| 2026-05-18 | RBC Capital | maintain | Sector Perform | Sector Perform |
| 2026-05-18 | Leerink Partners | downgrade | Market Perform | Outperform |
| 2026-05-18 | BMO Capital | maintain | Outperform | Outperform |
| 2026-05-18 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-05-01 | Guggenheim | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $54.15 | $17.61B | 10 |
| Sun Dec 31 | $60.88 | $18.92B | 8 |
| Mon Dec 31 | $72.07 | $20.97B | 6 |
| Tue Dec 31 | $71.47 | $21.46B | 6 |